Dalbavancin

Xydalba 500 mg poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 19 Feb 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

XydalbaEuropean UnionAuthorised

XydalbaCanada · 500 MG / VIAL · Powder For Solution · Knight Therapeutics INC.Same brand
Xydalba 500 MG de Polvo Para Concentrado Para Solucion Para PerfusionSpain · 516 mg · polvo para concentrado para solución para perfusión · Abbvie Deutschland Gmbh & Co. KgSame brand
XydalbaEuropean Union · AbbVie Deutschland GmbH & Co. KGSame brand
XydalbaCroatiaSame brand
XydalbaItaly · Polvere per concentrato per soluzione per infusione · Abbvie Deutschland GMBH & Co. KGSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dalbavancin

Xydalba 500 mg poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 19 Feb 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

XydalbaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

XYDALBA 500 mg

Romania · 500mg · pulb. pt. conc. pt. sol. perf. · Allergan Pharmaceuticals International LTD.

XYDALBA 500mgRomania · 500mg · pulb. pt. conc. pt. sol. perf. · Durata Therapeutics International BV

Dalbavancina Accord 500 MG Polvo Para Concentrado Para Solucion Para Perfusion EfgSpain · 500 mg · polvo para concentrado para solución para perfusión · Accord Healthcare S.L.U.

Dalbavancina Advanz Pharma 500 MG Polvo Para Concentrado Para Solucion Para Perfusion EfgSpain · 516 mg · polvo para concentrado para solución para perfusión · Advanz Pharma Limited

Dalbavancina AccordItaly · Polvere per concentrato per soluzione per infusione · Accord Healthcare, S.L.U.

Dalbavancina BaxterItaly · Polvere per concentrato per soluzione per infusione · Baxter Holding BV

Dalbavancin HydrochlorideUnited States · 500MG BASE/VIAL · powder · Be Pharms

DalvanceUnited States · 500MG BASE/VIAL · powder · Abbvie

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dalbavancin
Dosage form: Poeder voor concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 19 Feb 2015
Registration: EU/1/14/986
Marketing authorisation holder: AbbVie Deutschland GmbH & Co. KG
ATC code: J01XA04
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/002840
EU number: EU/1/14/986